Inventor · disambiguated record
Maureen Ryan
Also filed as: RYAN MAUREEN · RYAN MAUREEN C
10 granted patents·18 pending applications·74 citations·filing 1994–2025
88Inventor score
Top patents by PatentIndex Score
28 records- 0195US11078291B2BCMA antibodies and use of same to treat cancer and immunological disordersSEAGEN INC·Filed 2019·Granted Aug 3, 2021·8 cites·66 claims
- 0289US11767365B2BCMA antibodies and use of same to treat cancer and immunological disordersSEAGEN INC·Filed 2021·Granted Sep 26, 2023·1 cites·73 claims
- 0388US9120854B2Detection and treatment of pancreatic, ovarian and other cancersRYAN MAUREEN·Filed 2009·Granted Sep 1, 2015·25 cites·9 claims
- 0486US9587019B2CD33 antibodies and use of same to treat cancerSEATTLE GENETICS INC·Filed 2013·Granted Mar 7, 2017·7 cites·28 claims
- 0584US2024109975A1Bcma antibodies and use of same to treat cancer and immunological disordersSEAGEN INC·Filed 2023·Application pending·0 cites
- 0682US9493566B2Antibodies to integrin AVB6 and use of same to treat cancerSEATTLE GENETICS INC·Filed 2013·Granted Nov 15, 2016·9 cites·13 claims
- 0781US2023242648A1Antibodies to integrin avb6 and use of same to treat cancerSEAGEN INC·Filed 2023·Application pending·0 cites
- 0878US10787514B2CD33 antibodies and use of same to treat cancerSEATTLE GENETICS INC·Filed 2017·Granted Sep 29, 2020·1 cites·24 claims
- 0975US12268751B2Anti-αVβ6 antibodies and antibody-drug conjugatesSEAGEN INC·Filed 2023·Granted Apr 8, 2025·0 cites·15 claims
- 1074US2025135018A1Camptothecin peptide conjugatesSEAGEN INC·Filed 2023·Application pending·0 cites
- 1172US2021340260A1Antibodies to integrin avb6 and use of same to treat cancerSEAGEN INC·Filed 2021·Application pending·0 cites
- 1268US2019023801A1Bcma antibodies and use of same to treat cancer and immunological disordersSEATTLE GENETICS INC·Filed 2018·Application pending·0 cites
- 1368US2021047404A1Cd33 antibodies and use of same to treat cancerSEATTLE GENETICS INC·Filed 2020·Application pending·0 cites
- 1466US2019194338A1Bcma antibodies and use of same to treat cancer and immunological disordersSEATTLE GENETICS INC·Filed 2017·Application pending·0 cites
- 1565US2022193069A1Camptothecin peptide conjugatesSEAGEN INC·Filed 2021·Application pending·0 cites
- 1665US2020031938A1Antibodies to integrin avb6 and use of same to treat cancerSEATTLE GENETICS INC·Filed 2019·Application pending·0 cites
- 1763US2017233484A1Bcma antibodies and use of same to treat cancer and immunological disordersSEATTLE GENETICS INC·Filed 2017·Application pending·0 cites
- 1862US11827709B2Anti-AVB6 antibodies and antibody-drug conjugatesSEAGEN INC·Filed 2020·Granted Nov 28, 2023·0 cites·104 claims
- 1962US9725500B2Methods for screening antibodiesLYON ROBERT·Filed 2011·Granted Aug 8, 2017·1 cites·23 claims
- 2062US2025242041A1Anti-avb6 antibodies and antibody-drug conjugatesSEAGEN INC·Filed 2025·Application pending·0 cites
- 2158US2013309223A1CD33 Antibodies And Use Of Same To Treat CancerSEATTLE GENETICS INC·Filed 2013·Application pending·0 cites
- 2255US2023190949A1Methods of treating cancer using a combination of anti-cd30 antibody-drug conjugatesSEAGEN INC·Filed 2021·Application pending·0 cites
- 2353US2019343828A1Camptothecin peptide conjugatesSEATTLE GENETICS INC·Filed 2019·Application pending·0 cites
- 2452US6120991AEpiligrin, an epithelial ligand for integrinsHUTCHINSON FRED CANCER RES·Filed 1994·Granted Sep 19, 2000·22 cites·8 claims
- 2550US2016376368A1Antibodies to integrin avb6 and use of same to treat cancerSEATTLE GENETICS INC·Filed 2016·Application pending·0 cites
- 2647US2017298118A1Methods for screening antibodiesSEATTLE GENETICS INC·Filed 2017·Application pending·0 cites
- 2740US2016003847A1Detection and Treatment of Pancreatic, Ovarian and Other CD70 Positive CancersSEATTLE GENETICS INC·Filed 2015·Application pending·0 cites
- 2835US2019381171A1Co-use of anti-bcma antibody and antibody-coupled t cell receptor (actr) in cancer therapy and b cell disordersUNUM THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Maureen Ryan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →